The story of the erectile dysfunction drug presents a intricate picture for shareholders. While the initial introduction generated significant profits, the expiration of its exclusive rights opened the floodgates to https://atozbookmark.com/story21494023/viagra-and-the-pharmaceutical-industry-a-volatile-opportunity